Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Supply Chain

Manufacture Bioprocessing - Upstream & Downstream

Trials of a Medicine Maker

Will Gene's Supplier Exchange Program and eData skills get him what he wants?

Business & Regulation Business Practice

Perpetual Preparedness

| James Strachan

With a no-deal Brexit still a real possibility, Merck continues to prepare for the worst case scenario.

Business & Regulation Supply Chain

The Road to Interoperability

| Maryam Mahdi

The FDA has accepted TraceLink's blockchain and digital recall projects into its DSCSA Pilot Program.

Manufacture Advanced Medicine

Logistics Will Prevail

| Sam Herbert

Sam Herbert walks us through the past 50 years of pharma logistics.

Manufacture Bioprocessing - Single Use Systems

Strengthening Supply Chains with MilliporeSigma

| Sponsored by MilliporeSigma

As a leading partner and supplier to the industry, MilliporeSigma continues to strengthen and enhance its supply chain capabilities.

Manufacture Ingredients

A Lifetime of Achievement

| Maryam Mahdi

Sitting Down With... David Schoneker, Global Regulatory Director, Strategic Relationships at Colorcon.

Business & Regulation Trends & Forecasts

Aid Africa

| Stephanie Sutton

Healthcare, fake medicines, and the need for new antibiotics – a round-up from the UK East Africa Health Summit.

Business & Regulation Contract Manufacturing Services

(Block)chain Reaction

| Heather Zenk

Blockchain could be one solution to the saleable returns verification aspect of the US’ Drug Supply Chain Security Act.

Business & Regulation Trends & Forecasts

Ask, and Ye Shall Receive

| James Strachan

Regardless of how Britain leaves the European Union, the global pharma industry must always lobby for positive change.

Business & Regulation Business Practice

Facing the Brexit Trial

| James Strachan

No-deal Brexit poses unique challenges for the development and advanced therapy sectors, not least tight timelines and a limited ability to stockpile.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register